Fortress Biotech Inc (FBIO)
1.73
+0.01
(+0.58%)
USD |
NASDAQ |
Apr 26, 16:00
1.73
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Cash from Operations (TTM): -128.22M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -128.22M |
| September 30, 2023 | -141.13M |
| June 30, 2023 | -167.63M |
| March 31, 2023 | -175.76M |
| December 31, 2022 | -179.40M |
| September 30, 2022 | -170.25M |
| June 30, 2022 | -148.68M |
| March 31, 2022 | -141.71M |
| December 31, 2021 | -116.54M |
| September 30, 2021 | -98.33M |
| June 30, 2021 | -100.53M |
| March 31, 2021 | -83.48M |
| December 31, 2020 | -83.68M |
| September 30, 2020 | -88.25M |
| June 30, 2020 | -80.62M |
| March 31, 2020 | -91.53M |
| December 31, 2019 | -94.96M |
| September 30, 2019 | -92.07M |
| June 30, 2019 | -100.57M |
| March 31, 2019 | -96.33M |
| December 31, 2018 | -98.85M |
| September 30, 2018 | -97.55M |
| June 30, 2018 | -97.87M |
| March 31, 2018 | -97.67M |
| December 31, 2017 | -81.30M |
| Date | Value |
|---|---|
| September 30, 2017 | -78.41M |
| June 30, 2017 | -62.15M |
| March 31, 2017 | -45.65M |
| December 31, 2016 | -45.81M |
| September 30, 2016 | -34.90M |
| June 30, 2016 | -31.32M |
| March 31, 2016 | -30.11M |
| December 31, 2015 | -20.38M |
| September 30, 2015 | -16.84M |
| June 30, 2015 | -14.32M |
| March 31, 2015 | -12.16M |
| December 31, 2014 | -16.33M |
| September 30, 2014 | -19.94M |
| June 30, 2014 | -24.44M |
| March 31, 2014 | -28.23M |
| December 31, 2013 | -29.65M |
| September 30, 2013 | -29.62M |
| June 30, 2013 | -27.06M |
| March 31, 2013 | -25.26M |
| December 31, 2012 | -23.19M |
| September 30, 2012 | -19.75M |
| June 30, 2012 | -18.02M |
| March 31, 2012 | -14.59M |
| December 31, 2011 | -10.95M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-179.40M
Minimum
Dec 2022
-80.62M
Maximum
Jun 2020
-120.18M
Average
-100.57M
Median
Jun 2019
Cash from Operations (TTM) Benchmarks
| Journey Medical Corp | 5.24M |
| Avenue Therapeutics Inc | -9.451M |
| Checkpoint Therapeutics Inc | -47.59M |
| Viking Therapeutics Inc | -54.87M |
| Mustang Bio Inc | -49.48M |